Dive into this white paper to discover how Semalytix's unparalleled expertise is transforming patient journey development through advanced Large Language Models, enhancing care solutions and improving patient outcomes. #PatientJourney #LLM #AI #NLP #PatientExperience #PatientCentricity #PatientVoice #RWD #RWE #DiseaseBurden #PatientEngagement #BreastCancer #Psoriasis #Obesity #UlcerativeColitis #Melanoma #Lupus #Diabetes #CrohnsDisease
Semalytix
Softwareentwicklung
Bielefeld, Deutschland (DEU) 2.826 Follower:innen
Market-leading AI-powered patient-focused drug development solutions for Pharma
Info
Welcome to Semalytix! Semalytix, the trailblazer in AI-driven innovations, empowers pharmaceutical companies to embrace a patient-centric approach like never before. With their revolutionary Pharos platform, fuelled by state-of-the-art AI and LLM technology, Semalytix undertakes the colossal task of consuming and analysing millions of forum posts, social media discussions, and CRM system records in the blink of an eye. Pharos becomes the conduit for capturing and harnessing the pulse of real-world perceptions and experiences shared by both healthcare practitioners and patients in the here and now. Through its captivating living reports, Pharos bestows invaluable insights upon pharmaceutical giants, guiding them to laser-focus on their customers' genuine needs. It unlocks the profound understanding of what truly holds the potential to enhance their well-being, transforming lives in ways previously unimagined. Founded in 2015, Semalytix has grown to a team size of 75 employees and has executed more than 40 projects with the pharmaceutical industry with a total volume of EUR 3.8M between 2015 – 2019.
- Website
-
http://www.semalytix.com/
Externer Link zu Semalytix
- Branche
- Softwareentwicklung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Bielefeld, Deutschland (DEU)
- Art
- Privatunternehmen
- Gegründet
- 2015
- Spezialgebiete
- AI, NLP, Machine Learning, Deep Learning, Knowledge Graph, Predictive Analytics, Statistical Inference, Data Visualization, Big Data, Pharma und Real World Evidence
Produkte
Pharos
Software für E-Rezepte
Pharos Suite is a tool to support Pharma to prioritise drug developments with understanding unmet patient needs and treatment burdens.
Orte
-
Primär
Meller Straße 2
Bielefeld, Deutschland (DEU) 33613, DE
Beschäftigte von Semalytix
Updates
-
PatientGPT provides you with the finest precision analysis and deeper understanding derived from #patientnarratives. https://lnkd.in/gfyWy9cW What PatientGPT can do: - Rapid Insights: Tap into 50 million #patientexperience datapoints. - Precision Analysis: Gain a deeper understanding of medication benefits, disease burdens, and quality of life aspects directly from patient narratives. - Data-Rich, Time-Saving: Sidestep the exhaustive months of research with real-time insight extraction. - Intuitive Interface: Interactively “interview” or “converse with” global, disease-specific, patient experience records in 26 languages. #PatientCentricity #PatientExperience #PatientJourney #PatientVoice #AI #NLP
-
At Semalytix, we're thrilled to have played a crucial role in developing a groundbreaking paper that explores the optimal practices for ethical #patientengagement and #patientlistening on #socialmedia. Learn more by reading the full paper here: https://lnkd.in/eTNR9xfZ #sociallistening #rwd #rwe #patientcentricity
🚀🚀🚀 Incredibly happy to share this new collaborative publication 🧐🧐🧐 A discussion and proposal for best practices for ethical patient listening in #socialmedia, co-authored by #startups, #nonprofits, and #pharma that investigates the regulatory, industry, and patient perspective, as well as its benefits and honest limitations in making drug development more patient-focused: https://lnkd.in/ejZY4zWD This is the open, constructive, and collaborative spirit needed to keep pushing patient-centricity initiatives forward, which was made possible by the Pistoia Alliance. Announcements are quick and often don't do justice to the many hours of hard work of the many contributing authors: Philipp Cimiano, Ben Collins, Maria Carmela De Vuono, Thierry Escudier, Juergen Gottowik, Matthias Hartung, Mathias Leddin, Bikalpa Neupane (Bik), Ph.D., Raul Rodriguez-Esteban, Ana Lucía Schmidt, Cornelius Starke-Knäusel, Maarten Voorhaar, Krzysztof Więckowski Semalytix Bielefeld University Boehringer Ingelheim Chiesi Italia Pistoia Alliance Roche Takeda SageFiber #ai #pharmaceuticals #patientexperience #drugdevelopment #health #healthinnovation #gpt #llm #patients
-
We all need to be listening more to patients. At Semalytix, we give you the #patientvoice and their unmet needs. Discover how PatientGPT and Pharos can transform your approach to #patientinsights. With advanced analysis tools, you'll gain unparalleled access to patient narratives, enabling precision in understanding and decision-making. https://lnkd.in/eqPT_66a https://lnkd.in/euKZNkYz #patientcentricity #patientjourney #patientexperience #patientfocused #nlpproc #ai #llm #pharma #pharmaceuticals #drugdevelopment #realworlddata #realworldevidence
-
Highlights from our CPO and Co-Founder's engagement at the 5th Annual Patient-Centricity and Engagement World Congress in London. Over two enlightening days, we delved into the dynamic landscape of patient-centricity within life sciences and healthcare. The invaluable insights gleaned from discussions, panels sessions, and interactions are instrumental in shaping Semalytix's approach and vision moving forward. #patientcentricity #patientjourney #patientexperience #patientfocused #nlpproc #ai #llm #pharma #pharmaceuticals #drugdevelopment #realworlddata #realworldevidence
Following two days of listening to, reflecting about, and discussing the state of patient-centricity at the 5th Annual Patient-Centricity and Engagement World Congress in London, it’s worth a recap. Is patient-centricity in a new frontier? Never have the authorities required patient focus with such clarity. Never before has more patient (experience) data been available. Never before has #AI been more adept at making sense of complexity and finding patterns in data that humans can’t hope to understand. Nevertheless, data doesn’t make policy. #ai alone doesn’t change behaviour. Technology, on its own, is simply a tool and not an outcome. There’s a new door to walk through, but there’s still a very long way to go. I believe that, in the end, brilliant and remarkable individuals who won’t stop pushing for change will make the difference in making therapies and treatments in Life Science and Healthcare truly patient-centric. Thank you, Carole S., Usman Khan, Roi Shternin, and Gabor Purman, MD, MBA, for the excellent panel discussion! At Semalytix, we attended the congress with the hope that we could showcase where we are with our Patient Journey Generation approach and perhaps get a nudge in the right direction. We ended up spending two days meeting with some amazing people and learning much more about the reality and challenges that patients face than we could ever have imagined. Huge shoutout to everyone who took the time to speak with us, challenge us, and offer feedback. It’s truly appreciated, and we will weave our learnings into #PatientGPT to keep pushing its capabilities and, hopefully, its role in enabling more patient-focused drug development forward. Thank you, Jocelyn Raguindin, for organising the event, Emma Sutcliffe and Robert Mitchell-Thain, for leading the discussions on these two days, all the speakers, panelists, and vocal attendees. We are already looking forward to next year's installation! Victoria Harvey-Jones PhD Liz Clark Diana Reslan Bianca Swalem Debbie Cooke Bronwyn Lewis Gudula Petersen Jocelyn Raguindin Søren Eik Skovlund Dr. Andreas L.G. Reimann Linda Cowie Samantha Knott Sabine Friedl Kavitha Chakrapani Clara Matheus Keith Williams #patientcentricity #patientjourney #patientexperience #patientfocused #nlpproc #ai #llm #pharma #pharmaceuticals #drugdevelopment #realworlddata #realworldevidence
-
Join us at the 5th Patient Centricity & Collaboration World Congress 2024 where our Chief Product Officer and Co-Founder, Janik Jaskolski, will be a key speaker and panelist. Janik will be unveiling groundbreaking strategies for integrating #AI with #patientexperience data to revolutionise #patientjourney mapping, enhancing #patientengagement, and addressing the ethical dimensions of these innovations. He will also participate in a dynamic panel exploring the future of patient-centered methods in the pharmaceutical industry. This panel will delve into key topics such as driving innovation in #pharma, fostering deep partnerships with patients, harnessing #realworlddata to reshape #patientoutcomes, and leveraging cutting-edge technologies to put patients at the heart of #healthcare. Don't miss this chance to be part of a transformative dialogue on February 26th and 27th, 2024, at the Holiday Inn Bloomsbury, London. #NLP #patientcentricity #GenAi #semalytix
-
In the modern digital landscape, insightful data is a treasure, yet Social Media Listening is often underrated, seen as yielding insufficient and irrelevant information. At Semalytix, we are changing this narrative with our cutting-edge generative AI, PatientGPT. Our focus is not on the sheer volume of data but on the quality of insights derived from it. PatientGPT uniquely ensures that nearly all of our insights is thoughtfully derived from patients and relevant stakeholders, in stark contrast to the fractional relevance often associated with traditional Social Media Listening techniques. This innovation in Patient Listening sets us apart from standard Social Media Listening. Traditional approaches broadly scan various platforms for consumer behaviour and trends, but Patient Listening is specialised, honing in on patient experiences, their concerns, and discussions about health conditions and treatments. PatientGPT avoids the common failings of traditional methods, propelling us into a new era of meaning-centred social listening. Our approach transcends mere information gathering; it delves into a deep understanding of the subtleties and intricacies of #naturallanguage. Consider these real-world statements: "I'm lucky if I can make myself shower once a week." "Even tidying up a single room feels like a massive undertaking." "Preparing a basic meal can be a source of worry for me, and I often have to push myself to do it." Conventional social listening tools might wrongly categorise these statements as indicating sluggishness, primarily using keyword searches for interpretation. In contrast, PatientGPT's advanced analysis interprets these as expressions of individuals struggling with depression. Traditional methods, fixated on detecting specific keywords, often miss the depth of such insights. PatientGPT employs a nuanced, meaning-focused analysis, recognising the subtle ways in which people express complex conditions like depression, often without explicitly mentioning them. At Semalytix, PatientGPT is at the forefront of our endeavour to redefine Patient Listening. It specialises in discerning the #PatientVoice and #PatientPerspective across 25 indications in #Oncology #Metabolism #Respiratory #Central-Nervous Systems #Inflammatory and Rare Diseases. PatientGPT is crucial, not only for understanding patient journeys but also for gaining profound insights into the nuanced experiences and voices of patients. This comprehensive understanding unveils invaluable insights into patient experiences, enriching data-driven strategies with depth and precision, and enhancing decision-making processes within the Pharma sector. This comprehensive grasp sets our approach apart from traditional Social Media Listening methods, emphasising the importance of #naturallanguage in our analysis.
-
Use PatientGPT to explain real-world #patientexperiences, and use AI to create #patientjourneys based on thousands of patients. Discover how #PatientGPT and supervised #AI scale #evidence generation from a handful of patients to thousands.
-
Unveiling the Unseen with PatientGPT Every patient's journey holds hidden facets, those "unknown unknowns" that can make all the difference in care and outcomes. PatientGPT is your ally in bringing these critical insights to light. Discover the stories untold and the needs unspoken. Imagine having a dynamic, AI-generated map of patient experiences that guides pharmaceutical research towards the true north of patient needs. With PatientGPT, we're not just listening to the patient voice; we're amplifying it, making it the cornerstone of patient-centric drug development. Semalytix stands at the vanguard, with leading pharmaceutical companies already leveraging PatientGPT to illuminate paths to novel therapies and improved patient outcomes. #PatientGPT #PatientCentricity #PatientJourney #DrugDevelopment #PatientAdvocacy #ClinicalInnovation
-
🎥✨ Replay Alert! ✨🎥 Following an incredible session at the Institute for Science, Entrepreneurship and Investments event, where our Co-Founder and CPO, Janik Jaskolski, delivered a powerful keynote on the transformative role of deep tech in healthcare, we are excited to share the event recording! If you weren't able to join us live on November 6th to hear Janik’s visionary insights on AI's impact and its future potential, or simply want to revisit the inspiring discussions, the full session is now available online. Don't miss the chance to experience how Semalytix and other leaders are pioneering patient-centric health solutions through AI. Watch the recording to catch up on all the valuable insights shared by our esteemed guest speakers. Together, let's continue to innovate for a healthier world. #SemalytixImpact #HealthcareInnovation #AIHealthcare #DeepTech #LifeSciences
[Nov.6th, 2023] Tech Innovations In Healthcare, Pharma and Life Sciences [Nov.6th, 2023]
https://www.youtube.com/